Overview
TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease.
The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.
Eligibility
Inclusion Criteria:
- Patients between 18 and 60 years
- Signed informed consent
- Ulcerative colitis (UC) patients with active disease
- Crohn's disease (CD) patients with active disease
Exclusion Criteria:
- UC or CD patients in remission
- Patients between 18 and 60 years without informed consent